Hilo Secures Major Funding to Revolutionize Blood Pressure Care
Aktiia Announces Successful Series B Funding and Rebranding
Hilo, a leader in health technology focused on blood pressure management, has successfully completed an impressive $42 million Series B funding round. This oversubscribed funding round was co-led by renowned venture firms with both new and existing investors participating. With this latest investment, the company has surpassed a total of $100 million in funding to date, marking a significant milestone in its journey.
Investment Highlights and Future Prospects
This funding will significantly enhance Hilo's capabilities as it aims to transform blood pressure monitoring globally. With impressive achievements such as CE marking for its innovative mobile blood pressure monitoring technology, as well as regulatory approvals across multiple countries, the funding aims to accelerate product innovation and enable Hilo to expand its reach into new markets.
Innovative Technology and Growth Trajectory
Hilo has achieved notable momentum, showing a compounded annual revenue growth of 76% and successfully completing a crucial clinical trial ahead of its application submission to the authorities. This financial backing will allow the company to further develop its blood pressure intelligence platform, which is expected to support various enterprise applications.
A New Brand Identity - Welcome Hilo
As part of this significant change, Aktiia is officially rebranding to Hilo, reflecting its mission to provide easy and universal access to cuffless, clinically validated blood pressure monitoring technology. This rebranding represents a commitment to making blood pressure management as effortless as possible, while still providing high-quality technology and reports that users have come to trust.
Leading the Charge in Health Technology
With over 120,000 devices sold, Hilo stands tall as a pioneer in the health tech landscape. The company’s proprietary Machine Learning model has been meticulously engineered for blood pressure monitoring. This advanced model has utilized vast datasets of optical signals and calibration points derived from actual users, solidifying Hilo's place at the forefront of the cuffless blood pressure monitoring sector.
Leadership Insights
Raghav "Rags" Gupta, the CEO of Hilo, shares his thoughts: "This funding round underscores the belief our investors have in Hilo’s innovative technology and our objective to revolutionize blood pressure management. With billions of individuals facing hypertension, accessible and efficient blood pressure monitoring solutions are urgently needed. Our transformation to Hilo signifies more than a name change; it embodies our dedication to empowering users globally with advanced health management tools. We appreciate the support from our early customers and our investors, both new and old, who have shown us trust."
Investor Perspectives
Christoph Massner from Earlybird Health commented, "Hilo brilliantly merges medical-grade accuracy with consumer-friendly accessibility. By building on their validated medical device, Hilo empowers individuals to manage their health with ease, a critical factor given the serious public health challenge posed by uncontrolled high blood pressure."
About Hilo
Established in 2018, Hilo, formerly known as Aktiia, is committed to redefining blood pressure measurement through cutting-edge technology. The integration of sophisticated AI algorithms with extensive datasets allows for accurate monitoring, providing essential insights for individuals and healthcare professionals alike. Headquartered in Switzerland, Hilo has a dedicated team of experts and has contributed significantly to the scientific community through numerous publications and patents. The Hilo system is designed to enhance the understanding and management of blood pressure, though it is important to note that it should not be used to make medical diagnoses.
Frequently Asked Questions
What is the amount raised in Hilo's Series B funding round?
Hilo has successfully raised $42 million in its Series B funding round.
What does the rebranding to Hilo signify?
The rebranding reflects Hilo's commitment to making blood pressure monitoring more accessible and effortless for users globally.
What are Hilo’s plans for the future?
Hilo aims to innovate and expand its blood pressure intelligence platform, supporting both consumer and enterprise applications.
Who is the CEO of Hilo?
Raghav "Rags" Gupta is the CEO of Hilo, leading the company in its mission to transform blood pressure management.
Where is Hilo headquartered?
Hilo is based in Switzerland, where it continues to develop its cutting-edge technology for blood pressure monitoring.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.